z-logo
open-access-imgOpen Access
Gatifloxacin in combination with rifampicin in a murine tuberculosis model
Author(s) -
Michael H. Cynamon,
Mary Sklaney,
Carolyn Shoen
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm200
Subject(s) - gatifloxacin , rifampicin , tuberculosis , medicine , microbiology and biotechnology , antibacterial agent , virology , antibiotics , biology , pathology , levofloxacin
Gatifloxacin previously demonstrated good in vitro and in vivo activities against Mycobacterium tuberculosis. Several regimens of gatifloxacin in combination with rifampicin were compared with isoniazid plus rifampicin in a mouse tuberculosis model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom